{
    "clinical_study": {
        "@rank": "60351", 
        "arm_group": [
            {
                "arm_group_label": "R-CHOP-50", 
                "arm_group_type": "Active Comparator", 
                "description": "R-CHOP-50 (Rituximab 375 mg/m2 d1+Cyclophosphomide 750mg/m2 d2+Adriamycin 50mg/m2 d2+vincristine 1.4mg/m2 d2+Prednisone 60 mg/m2 d2-6) every 21 days for 6 cycles, followed by Rituximab 375 mg/m2 every 21 days for 2 cycles."
            }, 
            {
                "arm_group_label": "R-CEOP-70", 
                "arm_group_type": "Experimental", 
                "description": "R-CEOP-70 (Rituximab 375 mg/m2 d1+Cyclophosphomide 750mg/m2 d2+Adriamycin 70mg/m2 d2+vincristine 1.4mg/m2 d2+Prednisone 60 mg/m2 d2-6) every 21 days for 6 cycles, followed by Rituximab 375 mg/m2 every 21 days for 2 cycles."
            }, 
            {
                "arm_group_label": "R-CEOP-90", 
                "arm_group_type": "Experimental", 
                "description": "R-CEOP-90 (Rituximab 375 mg/m2 d1+Cyclophosphomide 750mg/m2 d2+Adriamycin 90mg/m2 d2+vincristine 1.4mg/m2 d2+Prednisone 60 mg/m2 d2-6) every 21 days for 6 cycles, followed by Rituximab 375 mg/m2 every 21 days for 2 cycles."
            }
        ], 
        "brief_summary": {
            "textblock": "The main purpose of this study is to evaluate the safety and efficacy of R-CEOP-90/R-CEOP-70\n      Versus R-CHOP-50 in the Treatment of Diffuse Large B-cell lymphoma patients."
        }, 
        "brief_title": "R-CEOP-90/R-CEOP-70 Versus R-CHOP-50 in the Treatment of Diffuse Large B-cell Lymphoma and Follicular Lymphoma Grade 3B", 
        "completion_date": {
            "#text": "April 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Diffuse Large B-cell Lymphoma", 
            "Follicular Lymphoma Grade 3B"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Lymphoma", 
                "Lymphoma, Follicular", 
                "Lymphoma, B-Cell", 
                "Lymphoma, Large B-Cell, Diffuse"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Histologically confirmed de novo diffuse large B-cell lymphoma or follicular lymphoma\n             grade 3B\n\n          2. Age>=16 y.o.,<=80 y.o.\n\n          3. ECOG < 3\n\n          4. No past history of malignancy\n\n          5. Radiologically measurable disease, CT imaging in screening showing 2 or more clearly\n             demarcated lesions with a largest diameter > 1.5 cm, or 1 clearly demarcated lesion\n             with a largest diameter > 2.0 cm.\n\n          6. Life expectancy>6 months\n\n          7. Informed consented\n\n        Exclusion Criteria:\n\n          1. Chemotherapy before\n\n          2. Bone marrow transplantation before\n\n          3. History of malignancy\n\n          4. Active infectious disease requiring general antibiotics, anti-fungal or anti-virus\n             therapy\n\n          5. Uncontrollable cardio-cerebral vascular, coagulative, autoimmune, serious infectious\n             disease\n\n          6. Primary cutaneous, CNS, mediastinal DLBCL\n\n          7. LVEF\u226450%\n\n          8. Other uncontrollable medical condition that may that may interfere the participation\n             of the study\n\n          9. Lab at enrollment(unless caused by lymphoma)\n\n               -  Neutrophile<1.5*10^9/L\n\n               -  Platelet<80*10^9/L\n\n               -  Hemoglobulin<100g/L\n\n               -  ALT or AST >2*ULN,AKP or bilirubin >1.5*ULN\n\n               -  Creatinine>1.5*ULN\n\n         10. Not able to comply to the protocol for mental or other unknown reasons\n\n         11. Pregnant or lactation\n\n         12. Active liver or biliary disease\n\n         13. If HbsAg positive, should check HBV DNA, DNA positive patients cannot be enrolled. If\n             HBsAg negative but HBcAb positive (whatever HBsAb status), should check HBV DNA,DNA\n             positive patients cannot be enrolled.\n\n         14. HIV infection"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "16 Years"
        }, 
        "enrollment": {
            "#text": "600", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01852435", 
            "org_study_id": "NHL-001"
        }, 
        "intervention": [
            {
                "arm_group_label": "R-CEOP-70", 
                "intervention_name": "R-CEOP-70", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "R-CEOP-90", 
                "intervention_name": "R-CEOP-90", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "R-CHOP-50", 
                "intervention_name": "R-CHOP-50", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "diffuse large B-cell lymphoma", 
            "follicular lymphoma grade 3B"
        ], 
        "lastchanged_date": "November 24, 2013", 
        "location": [
            {
                "contact": {
                    "email": "fugangdavid@163.com", 
                    "last_name": "Gang Fu"
                }, 
                "facility": {
                    "address": {
                        "city": "Chongqing", 
                        "country": "China", 
                        "state": "Chongqing"
                    }, 
                    "name": "Southwest Hospital"
                }, 
                "investigator": {
                    "last_name": "Jieping Chen", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "liutb@medmail.com.cn", 
                    "last_name": "Tingbo Liu"
                }, 
                "facility": {
                    "address": {
                        "city": "Fuzhou", 
                        "country": "China", 
                        "state": "Fujian"
                    }, 
                    "name": "Fujian Medical University Union Hospital"
                }, 
                "investigator": {
                    "last_name": "Jianda Hu", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "zhongliye99@163.com", 
                    "last_name": "Liye Zhong"
                }, 
                "facility": {
                    "address": {
                        "city": "Guangzhou", 
                        "country": "China", 
                        "state": "Guangdong"
                    }, 
                    "name": "Guangdong General Hospital"
                }, 
                "investigator": {
                    "last_name": "Xin Du", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "dong_lihua@qq.com", 
                    "last_name": "Lihua Dong"
                }, 
                "facility": {
                    "address": {
                        "city": "Zhengzhou", 
                        "country": "China", 
                        "state": "Henan"
                    }, 
                    "name": "Henan Cancer Hospital"
                }, 
                "investigator": {
                    "last_name": "Yongping Song", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jfzhou@tjh.tjmu.edu.cn", 
                    "last_name": "Jianfeng Zhou"
                }, 
                "facility": {
                    "address": {
                        "city": "Wuhan", 
                        "country": "China", 
                        "state": "Hubei"
                    }, 
                    "name": "Tongji Hospital"
                }, 
                "investigator": {
                    "last_name": "Jianfeng Zhou", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "lijianyonglm@medmail.com.cn", 
                    "last_name": "Jianyong Li"
                }, 
                "facility": {
                    "address": {
                        "city": "Nanjing", 
                        "country": "China", 
                        "state": "Jiangsu"
                    }, 
                    "name": "Jiangsu Province Hospital"
                }, 
                "investigator": {
                    "last_name": "Jianyong Li", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "hemozeno@gmail.com", 
                    "last_name": "Rui Zhang"
                }, 
                "facility": {
                    "address": {
                        "city": "Shenyang", 
                        "country": "China", 
                        "state": "Liaoning"
                    }, 
                    "name": "The first hospital of China medical university"
                }, 
                "investigator": {
                    "last_name": "Yan Li", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "wly6822@163.com", 
                    "last_name": "Lieyang Wang"
                }, 
                "facility": {
                    "address": {
                        "city": "Taiyuan", 
                        "country": "China", 
                        "state": "Shanxi"
                    }, 
                    "name": "Shanxi Provincial Tumor Hospital"
                }, 
                "investigator": {
                    "last_name": "Liping Su", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "tingniu@sina.com", 
                    "last_name": "Ting Niu"
                }, 
                "facility": {
                    "address": {
                        "city": "Chengdu", 
                        "country": "China", 
                        "state": "Sichuan"
                    }, 
                    "name": "West China Hospital"
                }, 
                "investigator": {
                    "last_name": "Ting Liu", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "benrun@sina.com", 
                    "last_name": "Wei Liu"
                }, 
                "facility": {
                    "address": {
                        "city": "Tianjin", 
                        "country": "China", 
                        "state": "Tianjin"
                    }, 
                    "name": "Institute of Hematology and Blood Diseases Hospital"
                }, 
                "investigator": {
                    "last_name": "Lugui Qiu", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "yujiejiang05@gmail.com", 
                    "last_name": "Yujie Jiang"
                }, 
                "facility": {
                    "address": {
                        "city": "Jinan", 
                        "country": "China"
                    }, 
                    "name": "Shandong Provincal Hospital"
                }, 
                "investigator": {
                    "last_name": "Xin Wang", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "zhao.weili@yahoo.com", 
                    "last_name": "Wei-Li Zhao, MD, PhD", 
                    "phone": "86-21-64370045", 
                    "phone_ext": "610707"
                }, 
                "contact_backup": {
                    "email": "xpproc@msn.com", 
                    "last_name": "Peng-Peng Xu, MD", 
                    "phone": "86-21-64370045", 
                    "phone_ext": "610707"
                }, 
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China", 
                        "zip": "200025"
                    }, 
                    "name": "Shanghai Ruijin Hospital"
                }, 
                "investigator": {
                    "last_name": "Wei-Li Zhao, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "3", 
        "official_title": "A Multi-center, Prospective, Randomized Phase III Study of the Safety and Efficacy of R-CEOP-90/R-CEOP-70 Versus R-CHOP-50 in the Treatment of Diffuse Large B-cell Lymphoma and Follicular Lymphoma Grade 3B", 
        "overall_contact": {
            "email": "zhao.weili@yahoo.com", 
            "last_name": "Wei-Li Zhao, MD,PhD", 
            "phone": "86-21-64370045", 
            "phone_ext": "610707"
        }, 
        "overall_contact_backup": {
            "email": "xpproc@msn.com", 
            "last_name": "Peng-peng Xu, MD", 
            "phone": "86-21-64370045", 
            "phone_ext": "610707"
        }, 
        "overall_official": {
            "last_name": "Weili Zhao, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "April 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "progression free survival", 
            "safety_issue": "No", 
            "time_frame": "2 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01852435"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ruijin Hospital", 
            "investigator_full_name": "Zhao Weili", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "overall survival", 
            "safety_issue": "No", 
            "time_frame": "2 year"
        }, 
        "source": "Ruijin Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ruijin Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}